Immuneel, HCB and IDIBAPS enter into a collaboration and licensing agreement for CAR T cell therapy
Immuneel acquires exclusive license to CD19 CAR T product for the potential treatment of B cell malignancies for India
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.